CYTOMX THERAPEUTICS I
0.9710
25-November-24 14:17:02
15 minutes delayed
Stocks
+0.0810
+9.10%
Today's range
0.8900 - 0.9950
ISIN
N/A
Source
NASDAQ
-
05 Jan 2023 15:05:00 By Nasdaq GlobeNewswire
-
22 Dec 2022 16:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
20 Dec 2022 16:00:00 By Nasdaq GlobeNewswire
-
07 Dec 2022 15:30:00 By Nasdaq GlobeNewswire
-
17 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
08 Nov 2022 15:10:00 By Nasdaq GlobeNewswire
-
07 Nov 2022 15:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming November Investor Conferences
02 Nov 2022 15:15:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022
01 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Phase 1 Data Update for anti-CTLA-4 Probody® Therapeutic BMS-986249
12 Sep 2022 07:00:02 By Nasdaq GlobeNewswire
-
07 Sep 2022 17:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
04 Aug 2022 15:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming Virtual August Investor Conferences
03 Aug 2022 07:00:02 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022
28 Jul 2022 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Provides Strategic Update
13 Jul 2022 15:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Phase 2 Results for Praluzatamab Ravtansine in Breast Cancer
06 Jul 2022 15:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
16 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Jefferies 2022 Global Healthcare Conference
01 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
26 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
05 May 2022 15:15:00 By Nasdaq GlobeNewswire